University College London Hospitals NHS Foundation Trust (UCLH)’s National Prion Clinic has been granted the go-ahead to test the use of a man-made antibody treatment (PRN100), with a view to halting or slowing the progression of sporadic CJD.
“We will proceed with extreme caution in very tightly-controlled conditions”. Professor John Collinge: Director of the Medical Research Council Prion Unit at University College London.
Therrien, A. (2018). Pioneering CJD treatment to be used on British patient. London: BBC Health News, October 9th 2018.